ArticleCancers2025

Clinical and Molecular Predictors of Response and Survival Following Venetoclax Plus Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Study in Chinese Patients.

Linya Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.